Eventually, I got everything together, played through Alyx, and had a great time. But, as rumors swirl that the announcement ...

Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has been given a consensus recommendation of “Buy” by the seven analysts that are presently covering the firm, Marketbeat Ratings reports.

Fluoride exposure appears to slightly decrease IQ scores in children, a new federal meta-analysis has concluded -- but not at ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

MBX Biosciences Inc. (NASDAQ:MBX) revealed results from its Phase 1 single ascending dose and multiple ascending dose trial ...

Combining Adderall with other CNS stimulants, such as caffeine, can increase the risk of side effects, including elevated ...

The reason I'm rushing you is because right over the horizon are a bunch of exciting new survival games. The survival genre ...

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

A compound derived from Nectandra leucantha, a tree native to southern Brazil (local names: canela-seca or canela-branca), ...

MBX Biosciences (MBX) announced positive results from its Phase 1 single ascending dose, SAD, and multiple ascending dose, MAD, clinical trial ...

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin ...